Stock: Stryker (SYK)Top Management and Board of DirectorsTop ManagementTop Management [Two top executives with tenure > 6 yrs]
Top Management [Five top executives with tenure < 1 yr]
Board Of DirectorsBoard Of Directors [Nine directors with tenure > 5 yrs]
Resignations in the past 2 years
Independent Ratings of Directors+ Ronda E. Stryker- Forbes Billionaires Ranking: Ronda E. Stryker was ranked 347 in the Forbes Billionaires list in the world for 2025, a deterioration from rank 312 in 2024. According to Forbes, Ronda E. Stryker's net worth had increased by (9,729.3%) $797.8 billion to $806 billion in 2025. + Kevin A. Lobo- Glassdoor Ranking: Kevin A. Lobo was ranked 54 in the Glassdoor Employee Review's list of 100 Top CEOs in the United States for 2021. Profiles of Top ManagementKevin A. LoboCEO & Chairman Mr. Lobo was named Chairman of the Board in July 2014 and has served as President and Chief Executive Officer of the Company since 2012. He joined the Company as a Group President in April 2011. Prior thereto, he held leadership roles over eight years with Johnson & Johnson, including president of Ethicon Endo-Surgery. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems. Mr. Lobo's global business and leadership experience across multiple industries, including healthcare, enables him to provide valuable insight to the Board regarding the Company's operations and the strategic planning initiatives necessary to meet the demands of the changing environment. As the sole member of management on our Board, he provides management's business perspectives and the necessary link to the day-to-day operations. Shareholder Value: Creation of shareholder value in Stryker: Date of appointment: July 22, 2014 In the last 10 years the average annualized return to shareholders was 16.6%. The present value of $1,000 (PV1000) invested 10 years ago is now $4,647, a gain of $3,385 and dividend reinvested of $261. Glassdoor Ranking: Kevin A. Lobo was ranked 54 in the Glassdoor Employee Review's list of 100 Top CEOs in the United States for 2021. Bill Berry Chief Administrative Officer & Vice President William (Bill) E. Berry Jr. became Vice President, Chief Accounting Officer in August 2021. Bill has oversight responsibility for the global accounting and financial functions and is responsible for internal reporting and consolidations, SEC and external reporting, financial accounting research, policies and procedures and our finance training and development programs. In addition, he is responsible for our global tax and internal audits. Bill joined Stryker in August 2011 as corporate controller. Before joining us, he served as the assistant corporate controller for Whirlpool Corporation, the world's leading global manufacturer and marketer of major home appliances, leading the accounting and reporting functions for the multi-national company. Previous roles include controller of the Electronics and Safety Division of Delphi Automotive LLP, a leading global vehicle components manufacturer from 2007 to 2009, and director of finance for global powertrain at Federal-Mogul Corporation, a leading global supplier of vehicle and industrial products. He began his career in public accounting at Deloitte & Touche LLP and earned a Bachelor's of Business Administration degree in accounting from Eastern Michigan University. Bill is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants. Alan Douville Vice President & Chief Information Officer Alan Douville became Vice President, Chief Information Officer and Chief Information Security Officer in September 2018. Alan leads our Global Information Technology Teams. He is responsible for the development and execution of our global information systems, as well as our information security vision, strategy and policy. Alan joined Stryker in January 2015, and since then he has been pivotal in defining and executing our major IT transformational programs. Previously he served as Whirlpool's Vice President of Global Information Systems Operations and Security, as well as Chief Information Officer of North America. Prior to Whirlpool, Alan was Senior Vice President of IT with Diageo PLC. Alan earned a bachelor's degree in electrical engineering and an MBA from the University of Maine. He is a certified information systems security professional (CISSP). Robert S. Fletcher Vice President & Chief Legal Officer Robert is responsible for the leadership and strategic direction of our global legal, compliance and corporate secretary functions. Throughout his career, he has gained deep leadership experience through managing complex, global business issues and has delivered strong results in the medical technology industry. Prior to joining us, Robert spent 15 years with Johnson & Johnson where he held multiple legal leadership roles including worldwide vice president of litigation and general counsel for the medical device and pharmaceutical sectors. He also served as corporate counsel for General Electric Aircraft Engines (now GE Aviation), which included work in mergers, acquisitions, joint ventures and divestitures. Before GE, Robert worked in private practice where he focused on corporate and real estate law. He earned a bachelor's degree in political science from The Ohio State University and a doctorate in law from Boston College Law School. Shareholder Value: Creation of shareholder value in Stryker: Month of appointment: April 2019 In the last 5 years the average annualized return to shareholders was 20.2%. The present value of $1,000 (PV1000) invested 5 years ago is now $2,514, a gain of $1,381 and dividend reinvested of $133. Lindsay Gardner Vice President Lindsey Gardner joined Stryker as Vice President, Treasurer in April 2024 Lindsay is responsible for our global Treasury function including treasury, risk, insurance and aviation. Prior to joining us, Lindsay spent 23 years with GE where she most recently served as Deputy Treasurer, leading corporate finance activities across credit ratings, capital structure, capital allocation, liquidity and bank relationships. In that role, Lindsay led the simplification and strengthening of the balance sheet to support the company's transformation and growth strategy. Prior to serving as Deputy Treasurer, Lindsay held various finance and risk management leadership positions in GE, including corporate audit, stress testing and capital adequacy. Lindsay holds a bachelor's degree in finance from Pennsylvania State University. Dana McMahon Vice President & Chief Compliance Officer Dana McMahon became Vice President, Chief Compliance Officer in January 2021. Dana leads global compliance and privacy activities at Stryker. Prior to her current role, Dana served as Chief Legal Counsel and led a global legal and compliance team advising on regulatory and quality, manufacturing and supply, technology and cybersecurity, commercial and government contracting, and privacy. Dana has more than 15 years of experience in the life sciences industry. She joined Stryker in 2017 from Novo Nordisk, where she served as Assistant General Counsel. During her 14-year career at Novo Nordisk, Dana held several positions of escalating responsibility within the legal team, overseeing support to the commercial, regulatory, clinical, medical affairs, compliance, and government affairs organizations. Dana has worked extensively on matters related to product development and commercialization, market access and compliance. Previously, Dana worked in private practice at O'Melveny in New York City. Dana received her law degree from New York University School of Law and her bachelor's degree from Hamilton College. Profiles of Board of DirectorsMary K. BrainerdDirector Director since 2017, Governance and Nominating Committee Chair, Compensation and Human Capital Committee Director of Bremer Financial Corporation and former President and Chief Executive Officer of HealthPartners Ms. Brainerd is the former President and Chief Executive Officer of HealthPartners, the largest, consumer-governed, nonprofit healthcare organization in the United States, which she led from 2002 to May 2017. Prior to joining HealthPartners in 1992, she held various executive roles with Blue Cross and Blue Shield of Minnesota from 1984 to 1992. She also serves as a director of Bremer Financial Corporation, a privately held regional financial services company. Ms. Brainerd's extensive experience surrounding both healthcare delivery and insurance enable her to provide unique and invaluable insight to our Board discussions, particularly in light of the evolving landscape in the healthcare delivery and payer markets. Shareholder Value: Creation of shareholder value in Stryker: Date of appointment: August 01, 2017 In the last 5 years the average annualized return to shareholders was 20.2%. The present value of $1,000 (PV1000) invested 5 years ago is now $2,514, a gain of $1,381 and dividend reinvested of $133. Giovanni Caforio Director Dr. Caforio has been CEO of Bristol Myers Squibb since May 2015 and assumed the role of Chairman of the Board in May 2017. As CEO, Dr. Caforio oversaw the acquisition of Celgene and has led the company's focus on researching and developing transformational medicines, which includes leading portfolios in oncology, hematology, immunology and cardiovascular disease. Previously, he spent 12 years with Abbott Laboratories in a number of leadership positions. Dr. Caforio also served as the Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association representing pharmaceutical companies in the United States. Dr. Caforio adds extensive experience to our board as both a physician and a business leader. As CEO of a leading global biopharmaceutical company, he has advanced scientific innovation that has helped improve the lives of patients. This experience will enable him to provide valuable business, leadership and management insights to our board. Shareholder Value: Creation of shareholder value in Stryker: Year of appointment: 2020 In the last 5 years the average annualized return to shareholders was 20.2%. The present value of $1,000 (PV1000) invested 5 years ago is now $2,514, a gain of $1,381 and dividend reinvested of $133. Skeete Tatum Lisa M Director Director since 2020, Audit Committee Founder and CEO, Landit, Inc. Ms. Skeete Tatum is the Founder and Chief Executive Officer of Landit, Inc., a technology platform created to increase the success and engagement of women and diverse groups in the workplace. Previously, she was a General Partner for over a decade with Cardinal Partners, a $350 million early-stage healthcare venture capital firm, where she focused on investments in healthcare technology. Ms. Skeete Tatum also worked for Procter & Gamble in various global and functional roles, including product development and product supply. She previously served on the boards of Surgical Care Affiliates, Inc., the Princeton Medical Center Foundation Board and numerous high growth medical technology companies. Ms. Skeete Tatum's experience in healthcare technology investing and her talent development skills, including her success in building a platform that enables companies and individuals to drive career improvement opportunities for everyone in the workplace lend valuable insights to our Board. Rachel Ruggeri Director Director since 2024, Audit Committee Executive Vice President and Chief Financial Officer, Starbucks Ms. Rachel Ruggeri is the Executive Vice President and Chief Financial Officer at Starbucks since 2021. As CFO of Starbucks, Ms. Ruggeri is responsible for the global finance function, including developing and executing financial strategies. Previously, she served as the Senior Vice President of Global Retail, with responsibility for the retail portfolio of Starbucks including company-operated and licensed/franchised stores across the globe. Since joining Starbucks in 2001, Ms. Ruggeri has held a variety of finance leadership positions within its North America and US businesses and led its Corporate Finance and Planning function. Ms. Ruggeri adds over 25 years of global finance leadership experience and valuable insights from a highly respected global consumer company to our Board. Rajeev Suri Independent Director President and Chief Executive Officer of Nokia, a leading global technology company, since April 2014. From 2009 to 2014, he was Chief Executive Officer of Nokia Solutions and Networks (previously Nokia Siemens Networks). Much of his nearly 30-year career has been spent in leadership roles at Nokia. He is also a United Nations Broadband Commissioner, a member of the steering committee of the Digital Communications Industry and a member of the stewardship Board of Health and Healthcare System Initiative at the World Economic Forum. Mr. Suri has deep business experience working across a range of functions, including strategy, mergers and acquisitions, marketing and sales. He has led a transformation of Nokia through significant portfolio adjustments, including the acquisition of Alcatel-Lucent, and has strong global experience. This background and Mr. Suri's extensive knowledge across a range of technology solutions are expected to provide critical input to our Board. Andrew K. Silvernail Independent Director Chairman, President and Chief Executive Officer of IDEX Corporation, Chairman since 2012 and President and Chief Executive Officer since 2011, and Vice President, Group Executive from January 2009 to August 2011. Mr. Silvernail is also a trustee for the Manufacturers Alliance for Productivity and Innovation (MAPI). By virtue of service as Chairman, President and Chief Executive Officer of IDEX Corporation and his prior experience in executive leadership positions with IDEX and another large public company, Mr. Silvernail provides valuable business, leadership and management insights and useful perspectives to our Board discussions. His experience leading a large public company with global operations gives him a clear understanding of the issues facing a multinational business such as ours. Shareholder Value: Creation of shareholder value in Stryker: Date of appointment: November 26, 2013 In the last 10 years the average annualized return to shareholders was 16.6%. The present value of $1,000 (PV1000) invested 10 years ago is now $4,647, a gain of $3,385 and dividend reinvested of $261. Sherilyn S. Mccoy Independent Director Director since 2018, Lead Independent Director, Compensation and Human Capital Committee, Governance and Nominating Committee Former CEO and Director of Avon Products, Inc. Ms. McCoy is former Chief Executive Officer and Director of Avon Products, Inc., a personal care products company, which she led for almost 6 years until she retired on February 4, 2018. Prior to joining Avon, Ms. McCoy had a 30-year career at Johnson & Johnson, where she led a variety of large medical device, pharmaceutical and consumer businesses and rose to the position of Vice Chair. She is also a director of AstraZeneca plc, a global, science-led biopharmaceutical company, and Kimberly-Clark Corporation, a multinational personal care corporation. Ms. McCoy has deep global experience as well as strong knowledge regarding mergers and acquisitions and the management of complex organizational structures. These skills, along with her background in the medical technology industry and extensive experience in a public company environment, enable her to bring valuable insights to our Board. Ronda E. Stryker Independent Director Granddaughter of the founder of the Company and daughter of a former President of the Company. She is also Vice Chair and a director of Greenleaf Trust, a Michigan chartered bank, Vice Chair of Spelman College, a trustee of Kalamazoo College and member of the Harvard Medical School Board of Fellows. Ms. Stryker brings a strong interest in advocating the benefits of diversity and various matters regarding social responsibility. As the Company's largest individual shareholder and a member of the founding family, she brings a strong shareholder perspective, unlike that of any other member of our Board, making her a valuable component of a well-rounded Board. Shareholder Value: Creation of shareholder value in Stryker: Year of appointment: 1984 In the last 20 years the average annualized return to shareholders was 12.5%. The present value of $1,000 (PV1000) invested 20 years ago is now $10,605, a gain of $9,008 and dividend reinvested of $596. Forbes Billionaires Ranking: Ronda E. Stryker was ranked 347 in the Forbes Billionaires list in the world for 2025, a deterioration from rank 312 in 2024. According to Forbes, Ronda E. Stryker's net worth had increased by (9,729.3%) $797.8 billion to $806 billion in 2025. Allan C. Golston Lead Independent Director Director since 2011, Compensation and Human Capital Committee Chair, Governance and Nominating Committee President, United States Program for the Bill & Melinda Gates Foundation Mr. Golston is the President, United States Program for the Bill & Melinda Gates Foundation since 2006, and served as Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories. Mr. Golston has extensive experience in auditing, finance and the healthcare industry. He is a certified public accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital. In his service to the Gates Foundation, he has contributed to the strategic formation and operation of successful initiatives to provide healthcare, education and other human needs, all of which give him an understanding that assists us in our global efforts to meet the needs of patients and caregivers. |